Abstract

Artificial sweeteners (AS) have been widely used as sugar substitutes to reduce calorie intake. However, it was reported that high doses of AS induced glucose intolerance via modulating gut microbiota. The objective of this study was to investigate the effects of lower doses of sucralose on fecal microbiota in obesity. Eight weeks after high-fat diet (HFD), the male Sprague Dawley rats were randomly divided into four groups (6 in each group) and administrated by a daily gavage of 2 ml normal saline (CON), 0.54 mM sucralose (N054), 0.78 mM sucralose (N078), and 324 mM sucrose (S324), respectively. After 4 weeks, fecal samples were obtained and analyzed by 16S ribosomal RNA gene sequencing. The richness and diversity of fecal microbiota were not changed by sucralose or sucrose. Both 0.54 mM (0.43 mg) and 0.78 mM (0.62 mg) sucralose tended to reduce the beneficial bacteria, Lactobacillaceae and Akkermansiaceae. The relative abundance of family Acidaminoccaceae and its genus Phascolarctobacteriam were increased after 0.54 mM sucralose. In functional prediction, 0.54 mM sucralose increased profiles of carbohydrate metabolism, whereas 0.78 mM sucralose enhanced those of amino acid metabolism. The lower doses of sucralose might alter the compositions of fecal microbiota. The effects of sucralose in different dosages should be considered in the future study.

Highlights

  • Obesity has emerged as a major public health challenge affecting over 650 million adults worldwide

  • The principal coordinates analysis (PCoA) plot revealed that most samples treated by 0.78 mM sucralose clustered in a distinct group compared with CON, N054, and S324 groups (PERMANOVA, p = 0.001 and p adjust = 0.001)

  • We demonstrated 4-week low doses of sucralose (0.54 and 0.78 mM) altered the compositions and metabolic functions of fecal microbiota in obese rats

Read more

Summary

Introduction

Obesity has emerged as a major public health challenge affecting over 650 million adults worldwide. It increases the risks of type 2 diabetes, cardiovascular diseases, and even certain cancers [1]. Table sugars contribute to the weight gain and thereby risks for metabolic disorders [2, 3]. Artificial sweeteners (AS) are widely used as sugar substitutes to provide intensive sweet taste without extra calorie. The US Food and Drug Administration (FDA) provided the acceptable daily intake (ADI) levels of 6 kinds of AS including saccharin, aspartame, acesulfame potassium (Ace-K), sucralose, neotame, and advantame [4]. Some studies demonstrated the benefits of AS exposure [5], whereas others showed that AS were associated with the incidence of obesity and type 2 diabetes [6,7,8]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call